Safety and Antiviral Activity Study of ACH-126,443 (Beta-L-Fd4C) in Treatment-naive Adults With Chronic Hepatitis B Virus Infection
Clinical trial NCT00034359 · COMPLETED
Trial details
- NCT number
- NCT00034359
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-02-01
- Primary completion
- 2003-01-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.